Reduced glomerular filtration rate, inflammation and HDL cholesterol as main determinants of superoxide production in non-dialysis chronic kidney disease patients

References

• Loughrey CM, Young IS, Lightbody JH, McMaster D, McNamee PT, Trimble ER. Oxidative stress in haemodialysis. Q J Med 1994;87:679–683.
   Google Scholar
• Cristol JP, Maggi MF, Bosc JY, Badiou S, Delage M, Vernet MH, Michel F, Castel J, Canaud B, Descomps B. Oxidative stress and chronic renal insufficiency: what can be a prophylactic approach? C R Seances Soc Biol Fil 1997;191:603–616.
   PubMedGoogle Scholar
• Witko-Sarsat V, Friedlander M, Capeillere-Blandin C, Nguyen-Khoa T, Nguyen AT, Zingraff J, Jungers P, Descamps-Latscha B. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 1996;49: 1304–1313.
   PubMed Web of Science ®Google Scholar
• Witko-Sarsat V, Friedlander M, Nguyen Khoa T, Capeillere-Blandin C, Nguyen AT, Canteloup S, Dayer JM, Jungers P, Drueke T, Descamps-Latscha B. Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. J Immunol 1998;161:524–2532.
   Web of Science ®Google Scholar
• Tarng DC, Huang TP, Liu TY, Chen HW, Sung YJ, Wei YH. Effect of vitamin E-bonded membrane on the 8-hydroxy 2′-deoxyguanosine level in leukocyte DNA of hemodialysis patients. Kidney Int 2000;58:790–799.
   PubMed Web of Science ®Google Scholar
• Massy ZA, Stenvinkel P, Drueke TB. The role of oxidative stress in chronic kidney disease. Semin Dial 2009;22:405–408.
   PubMed Web of Science ®Google Scholar
• Hasselwander O, Young I. Oxidative stress in chronic renal failure. Free Radic Res 1998;29:1–11.
   PubMed Web of Science ®Google Scholar
• Ward R, McLeish K. Polymorphonuclear leukocyte oxidative burst is enhanced in patients with chronic renal insufficiency. J Am Soc Nephrol 1994;5:1697–1702.
   Web of Science ®Google Scholar
• Chen MF, Chang CL, Liou SY. Increase in resting levels of superoxide anion in the whole blood of uremic patients on chronic hemodialysis. Blood Purif 1998;16:290–300.
   PubMed Web of Science ®Google Scholar
• Figarola JL, Shanmugam N, Natarajan R, Rahbar S. Anti-inflammatory effects of the advanced glycation end product inhibitor LR-90 in human monocytes. Diabetes 2007;56:647–655.
   PubMed Web of Science ®Google Scholar
• Ungvari Z, Csiszar A, Edwards JG, Kaminski PM, Wolin MS, Kaley G, Koller A. Increased superoxide production in coronary arteries in hyperhomocysteinemia: role of tumor necrosis factor-alpha, NAD(P)H oxidase, and inducible nitric oxide synthase. Arterioscler Thromb Vasc Biol 2003;23:418–424.
   PubMed Web of Science ®Google Scholar
• Ventura E, Durant R, Jaussent A, Picot MC, Morena M, Badiou S, Dupuy AM, Jeandel C, Cristol JP. Homocysteine and inflammation as main determinants of oxidative stress in the elderly. Free Radic Biol Med 2009;46:737–744.
   PubMed Web of Science ®Google Scholar
• Prasad K. C-reactive protein increases oxygen radical generation by neutrophils. J Cardiovasc Pharmacol Ther 2004;9: 203–209.
   PubMed Web of Science ®Google Scholar
• Lander H. An essential role for free radicals and derived species in signal transduction. FASEB J 1997;11:118–124.
   PubMed Web of Science ®Google Scholar
• Acker H. The oxygen sensing signal cascade under the influence of reactive oxygen species. Philos Trans R Soc Lond B Biol Sci 2005;360:2201–2210.
   PubMed Web of Science ®Google Scholar
• Lonnemann G. Chronic inflammation in hemodialysis: the role of contaminated dialysate. Blood Purif 2000;18:214–223.
   PubMed Web of Science ®Google Scholar
• Zoccali C. Traditional and emerging cardiovascular and renal risk factors: an epidemiologic perspective. Kidney Int 2006;70:26–33.
   PubMed Web of Science ®Google Scholar
• Goolsby MJ. National Kidney Foundation Guidelines for chronic kidney disease: evaluation, classification, and stratification. J Am Acad Nurse Pract 2002;14:238–242.
   PubMedGoogle Scholar
• Benetos A, Safar M, Rudnichi A, Smulyan H, Richard JL, Ducimetieere P, Guize L. Pulse pressure: a predictor of long-term cardiovascular mortality in a French male population. Hypertension 1997;30:1410–1415.
   PubMed Web of Science ®Google Scholar
• Badiou S, Dupuy AM, Descomps B, Cristol JP. Comparison between the enzymatic vitros assay for creatinine determination and three other methods adapted on the Olympus analyzer. J Clin Lab Anal 2003;17:235–240.
   PubMed Web of Science ®Google Scholar
• Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, Kusek JW, Van Lente F. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006;145:247–254.
   PubMed Web of Science ®Google Scholar
• Mickey RM, Greenland S. The impact of confounder selection criteria on effect estimation. Am J Epidemiol 1989;129:125–137.
   PubMed Web of Science ®Google Scholar
• Karamouzis I, Sarafidis PA, Karamouzis M, Iliadis S, Haidich AB, Sioulis A, Triantos A, Vavatsi-Christaki N, Grekas DM. Increase in oxidative stress but not in antioxidant capacity with advancing stages of chronic kidney disease. Am J Nephrol 2008;28:397–404.
   PubMed Web of Science ®Google Scholar
• Terawaki H, Yoshimura K, Hasegawa T, Matsuyama Y, Negawa T, Yamada K, Matsushima M, Nakayama M, Hosoya T, Era S. Oxidative stress is enhanced in correlation with renal dysfunction: examination with the redox state of albumin. Kidney Int 2004;66:1988–1993.
   PubMed Web of Science ®Google Scholar
• Oberg BP, McMenamin E, Lucas FL, McMonagle E, Morrow J, Ikizler TA, Himmelfarb J. Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease. Kidney Int 2004;65:1009–1016.
   PubMed Web of Science ®Google Scholar
• Himmelfarb J, McMonagle E, McMenamin E. Plasma protein thiol oxidation and carbonyl formation in chronic renal failure. Kidney Int 2000;58:2571–2578.
   PubMed Web of Science ®Google Scholar
• Landray MJ, Wheeler DC, Lip GY, Newman DJ, Blann AD, McGlynn FJ, Ball S, Townend JN, Baigent C. Inflammation, endothelial dysfunction, and platelet activation in patients with chronic kidney disease: the chronic renal impairment in Birmingham (CRIB) study. Am J Kidney Dis 2004;43:244–253.
   PubMed Web of Science ®Google Scholar
• Stuveling EM, Hillege HL, Bakker SJ, Asselbergs FW, de Jong PE, Gans RO, de Zeeuw D. C-reactive protein and microalbuminuria differ in their associations with various domains of vascular disease. Atherosclerosis 2004;172:107–114.
   PubMed Web of Science ®Google Scholar
• Clay MA, Pyle DH, Rye KA, Vadas MA, Gamble JR, Barter PJ. Time sequence of the inhibition of endothelial adhesion molecule expression by reconstituted high density lipoproteins. Atherosclerosis 2001;157:23–29.
   PubMed Web of Science ®Google Scholar
• Navab M, Hama SY, Cooke CJ, Anantharamaiah GM, Chaddha M, Jin L, Subbanagounder G, Faull KF, Reddy ST, Miller NE, Fogelman AM. Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: step 1. J Lipid Res 2000;41:1481–1494.
   PubMed Web of Science ®Google Scholar
• Van Lenten BJ, Navab M, Shih D, Fogelman AM, Lusis AJ. The role of high-density lipoproteins in oxidation and inflammation. Trends Cardiovasc Med 2001;11:155–161.
   PubMed Web of Science ®Google Scholar
• Arakawa H, Qian JY, Baatar D, Karasawa K, Asada Y, Sasaguri Y, Miller ER, Witztum JL, Ueno H. Local expression of platelet-activating factor-acetylhydrolase reduces accumulation of oxidized lipoproteins and inhibits inflammation, shear stress-induced thrombosis, and neointima formation in balloon-injured carotid arteries in nonhyperlipidemic rabbits. Circulation 2005;111:3302–3309.
   PubMed Web of Science ®Google Scholar
• Mertens A, Verhamme P, Bielicki JK, Phillips MC, Quarck R, Verreth W, Stengel D, Ninio E, Navab M, Mackness B, Mackness M, Holvoet P. Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis. Circulation 2003;107:1640–1646.
   PubMed Web of Science ®Google Scholar
• Jurek A, Turyna B, Kubit P, Klein A. The ability of HDL to inhibit VCAM-1 expression and oxidized LDL uptake is impaired in renal patients. Clin Biochem 2008;41:1015–1018.
   PubMed Web of Science ®Google Scholar
• Morena M, Cristol JP, Dantoine T, Carbonneau MA, Descomps B, Canaud B. Protective effects of high-density lipoprotein against oxidative stress are impaired in haemodialysis patients. Nephrol Dial Transplant 2000;15:389–395.
   PubMed Web of Science ®Google Scholar
• Vaziri ND. Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences. Am J Physiol Renal Physiol 2006;290:262–272.
   PubMed Web of Science ®Google Scholar
• Van Lenten BJ, Hama SY, de Beer FC, Stafforini DM, McIntyre TM, Prescott SM, La Du BN, Fogelman AM, Navab M. Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures. J Clin Invest 1995;96:2758–2767.
   PubMed Web of Science ®Google Scholar
• Mitnick MA, Grey A, Masiukiewicz U, Bartkiewicz M, Rios-Velez L, Friedman S, Xu L, Horowitz MC, Insogna K. Parathyroid hormone induces hepatic production of bioactive interleukin-6 and its soluble receptor. Am J Physiol Endocrinol Metab 2001;280:405–412.
   Web of Science ®Google Scholar
• Sun Y, Ahokas RA, Bhattacharya SK, Gerling IC, Carbone LD, Weber KT. Oxidative stress in aldosteronism. Cardiovasc Res 2006;71:300–309.
   PubMed Web of Science ®Google Scholar
• Yamamoto M, Clark JD, Pastor JV, Gurnani P, Nandi A, Kurosu H, Miyoshi M, Ogawa Y, Castrillon DH, Rosenblatt KP, Kuro-o M. Regulation of oxidative stress by the anti-aging hormone klotho. J Biol Chem 2005;280: 38029–38034.
   PubMed Web of Science ®Google Scholar
• Djamali A, Vidyasagar A, Adulla M, Hullett D, Reese S. Nox-2 is a modulator of fibrogenesis in kidney allografts. Am J Transplant 2009;9:74–82.
   PubMed Web of Science ®Google Scholar
• Goux A, Feillet-Coudray C, Jover B, Fouret G, Bargnoux AS, Cassan C, Richard S, Badiou S, Cristol JP. NADPH oxidase activity is associated with cardiac osteopontin and pro-collagen type I expression in uremia. Free Radic Res. 2011 Apr;45(4): 454–460.
   PubMed Web of Science ®Google Scholar
• Morena M, Gausson V, Mothu N, Bouchet JL, Chanas M, Grandvuillemin M, Robert A, Vela C, Canaud B, Cristol JP, Olmer M. Regional variations of low-density lipoprotein oxidizability in hemodialysis patients may explain discrepancies in interventional therapy on oxidative profile. Blood Purif 2008;26:300–310.
   PubMed Web of Science ®Google Scholar